TREACE MEDICAL CONCEPTS, INC.

By person

21 insiders · 252 transactions

73.1×

John T. Treace holds 73.1 times base salary in stock. $55.23M of shares against $755.35K in salary for 2025.

Salary from the company's own proxy. The shares are what John T. Treace last reported holding, valued at $4.34, the price Common Stock was last bought or sold at on the open market here, on 24 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Treace John T.

Chief Executive Officer

$7.34M (26)

$98.59M (27) scheduled

−$91.25M

12,728,512

$55.23M

−19.2%

BAYS F BARRY

Former Director

—

$44.25M (45)

−$44.25M

$0.00

−100.0%

TREACE JAMES T

Director

$2.07M (6)

$18.24M (55)

−$16.17M

3,725,757

$16.17M

−29.2%

MOTT RICHARD W

Director

$694.86K (4)

$16.39M (22)

−$15.70M

1,498,111

$6.50M

+7.0%

TIMBIE THOMAS E

Director

—

$10.96M (14)

−$10.96M

3,971,604

$17.23M

−20.0%

TREACE JOHN R

Director

—

$7.87M (5) scheduled

−$7.87M

5,232,833

$22.71M

−0.9%

Frias Jaime A.

Chief Legal Officer

—

$5.60M (1) scheduled

−$5.60M

276,210

$1.20M

−41.1%

Scanlan Sean F.

Chief Innovation Officer

—

$5.40M (16) scheduled

−$5.40M

679,863

$2.95M

—

BAKEWELL JOHN K

Director

$594.62K (1)

—

+$594.62K

546,356

$2.37M

—

Owens Daniel E.

Chief Human Resources Officer

$68.00K (1)

$565.07K (12) scheduled

−$497.07K

30,914

$134.14K

—

Hair Mark

Chief Financial Officer

$329.16K (3)

$25.39K (1)

+$303.77K

918,500

$3.99M

—

Jain Deepti

Director

$112.57K (1)

—

+$112.57K

100,243

$434.97K

—

Kiernan Jane E

Director

$100.00K (1)

—

+$100.00K

93,949

$407.66K

—

Elder Scot Michael

Chief Legl & Comp Off, CorpSec

$80.23K (1)

$18.70K (2)

+$61.53K

778,683

$3.38M

+4,357%

Lubben Terry W.

SVP, Operations

$46.55K (1)

—

+$46.55K

5,850

$25.38K

—

Berutti Aaron

SVP, Sales

$39.89K (1)

$17.89K (1)

+$22.00K

205,092

$889.94K

—

Ferguson Joe W.

SVP, Research & Development

—

505,331

$2.19M

+354.8%

Guglielmino Gaetano

Chief Commercial Officer

—

490,901

$2.13M

—

Hanna Betsy

Director

—

75,243

$326.49K

—

Berry Lance A

Director

—

74,593

$323.67K

—

HAMILTON LAWRENCE W

Director

—

74,056

$321.34K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Scanlan Sean F.

17 Mar 2025

Chief Innovation Officer

Sold after exercise

50,000

$7.97

$398.46K

Scanlan Sean F.

16 May 2023

Chief Innovation Officer

Sold after exercise

25,000

$25.44

$635.98K

Owens Daniel E.

15 Mar 2023

Chief Human Resources Officer

Sold after exercise

6,250

$22.87

$142.96K

Scanlan Sean F.

15 Feb 2023

Chief Innovation Officer

Sold after exercise

25,000

$21.69

$542.24K

Scanlan Sean F.

12 Jan 2023

Chief Innovation Officer

Sold after exercise

25,000

$25.57

$639.31K

Owens Daniel E.

2 Dec 2022

Chief Human Resources Officer

Sold after exercise

1,875

$25.00

$46.88K

Owens Daniel E.

2 Dec 2022

Chief Human Resources Officer

Sold after exercise

3,750

$25.00

$93.75K

Owens Daniel E.

15 Nov 2022

Chief Human Resources Officer

Sold after exercise

6,250

$20.38

$127.37K

Scanlan Sean F.

14 Nov 2022

SVP, Marketing

Sold after exercise

25,000

$24.27

$606.68K

Owens Daniel E.

2 Sep 2022

Chief Human Resources Officer

Sold after exercise

1,500

$20.04

$30.06K

Owens Daniel E.

1 Sep 2022

Chief Human Resources Officer

Sold after exercise

1,000

$19.50

$19.50K

Owens Daniel E.

15 Aug 2022

Chief Human Resources Officer

Sold after exercise

1,500

$20.00

$30.00K

Owens Daniel E.

1 Aug 2022

Chief Human Resources Officer

Sold after exercise

1,000

$16.89

$16.89K

Owens Daniel E.

5 Jul 2022

Chief HR Officer

Sold after exercise

1,000

$15.00

$15.00K

Owens Daniel E.

1 Jun 2022

Chief HR Officer

Sold after exercise

1,000

$16.67

$16.67K

Owens Daniel E.

9 May 2022

Chief HR Officer

Sold after exercise

1,000

$15.96

$15.96K

Scanlan Sean F.

2 Mar 2022

SVP, Marketing

Sold after exercise

25,000

$20.82

$520.55K

Scanlan Sean F.

9 Feb 2022

SVP, Marketing

Sold after exercise

3,873

$20.16

$78.08K

Scanlan Sean F.

8 Feb 2022

SVP, Marketing

Sold after exercise

21,127

$20.02

$422.89K

Scanlan Sean F.

11 Jan 2022

SVP, Marketing

Sold after exercise

8,838

$20.12

$177.85K

Scanlan Sean F.

10 Jan 2022

SVP, Marketing

Sold after exercise

38,862

$20.16

$783.53K

Scanlan Sean F.

5 Jan 2022

SVP, Marketing

Sold after exercise

800

$20.02

$16.02K

Scanlan Sean F.

4 Jan 2022

SVP, Marketing

Sold after exercise

500

$20.00

$10.00K

Scanlan Sean F.

3 Jan 2022

SVP, Marketing

Sold after exercise

1,000

$20.02

$20.02K

Scanlan Sean F.

10 Nov 2021

SVP, Marketing

Sold after exercise

440

$22.20

$9.77K

Scanlan Sean F.

10 Nov 2021

SVP, Marketing

Sold after exercise

24,560

$21.53

$528.66K

Frias Jaime A.

27 Apr 2021

See Remarks

Sold after exercise

329,230

$17.00

$5.60M

TREACE JOHN R

27 Apr 2021

Director

Sold after exercise indirect

401,250

$17.00

$6.82M

Showing 250 of 252 transactions. The figures above use every one of them.

TREACE MEDICAL CONCEPTS, INC.

By person

Individual transactions

What was left out